In accord with this week's 7th annual World Rare Disease Day, Arizonans and patients from throughout the nation and around the globe are benefitting from rare disease research conducted by the non-profit Translational Genomics ...
Feb 27, 2014
0
5
Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound ...
Sep 12, 2013
0
1
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when ...
Jul 17, 2013
0
0
As if the story of breakthrough research were not enough, there is the story of the researcher. The accomplishment, in this case, is a rapid test for detecting devastating bacterial infections. The researcher is undergraduate ...
May 8, 2013
0
0
The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American ...
Apr 9, 2013
0
0
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute (TGen) will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Apr 3, 2013
0
0
The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Mar 27, 2013
0
0
More northwest Ohio garden centers this spring are teaming up with an Arizona-based biomedical research organization to fight pancreatic cancer through the sale of purple flowers, which symbolize the nation's fourth leading ...
Mar 19, 2013
0
0
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard ...
Jan 22, 2013
0
0
Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) ...
Dec 6, 2012
0
0
